NCT01938105

Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer

Preoperative Concurrent Chemoradiotherapy Combined With Nimotuzumab Injection for Locally Advanced Cervical Cancer: a Phase II Study

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: People's Hospital of Guangxi Zhuang Autonomous Region · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the feasibility and efficacy of preoperative nimotuzumab injection combined with concurrent chemoradiotherapy for initially inoperable, locally advanced cervical cancer.

Conditions

• Locally Advanced Cervical Cancer

Interventions

Type	Name	Description
OTHER	Nimotuzumab+chemoradiotherapy	Nimotuzumab 200mg per week will be administered concurrent with platinum-based chemotherapy and intensity-modulated radiation therapy. After the preoperative treatment, patients will be assessed for tumor response and operability. For those who are considered to be candidates for operation, radical surgery will be performed. \--------------------------------------------------------------------------------

Timeline

• Start date: 2013-07-01
• Primary completion: 2015-06-01
• Completion: 2016-06-01
• First posted: 2013-09-10
• Last updated: 2013-09-26

Locations

1 site across 1 country: China